1. Kanis JA. WHO scientific group technical report: assessment of osteoporosis at the primary health care level. UK. WHO. 2007;1–339.
https://www.sheffield.ac.uk/FRAX/pdfs/WHO_Technical_Report.pdf
. Accessed 08 Aug 2017.
2. Cooper C, Campion G, Melton LJ. Hip fracture in the elderly: a world-wide projection. Osteoporos Int. 1992;2:285–9.
3. Schneider JK, Nickman NA. Assessment of pharmaceutical care needs in an ambulatory setting. Hosp Pharm. 1994;29:238–42.
4. Van Boven JFM, Stuurman Bieze AGG, Hiddink EG, Postma MJ, Vegter S. Medication monitoring and optimization: a targeted pharmacist program for effective and cost-effective improvement of chronic therapy adherence. J Manag Care Spec Pharm. 2014;20(8):786–92.
5. Stuurman-Bieze AGG, Hiddink EG, van Boven JFM, Vegter S. Proactive pharmaceutical care interventions decrease patients’ nonadherence to osteoporosis medication. Osteoporos Int. 2014;25:1807–12.